These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34491673)

  • 61. Side-effects of antileprosy drugs in common use.
    Jopling WH
    Lepr Rev; 1983 Dec; 54(4):261-70. PubMed ID: 6199637
    [No Abstract]   [Full Text] [Related]  

  • 62. Chemoimmunotherapy: its relevance in contemporary context.
    Sehgal VN; Jain S
    Int J Dermatol; 1994 Oct; 33(10):753-4. PubMed ID: 8002151
    [No Abstract]   [Full Text] [Related]  

  • 63. Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient.
    Barot RK; Viswanath V; Pattiwar MS; Torsekar RG
    Indian J Ophthalmol; 2011; 59(4):328-9. PubMed ID: 21666328
    [No Abstract]   [Full Text] [Related]  

  • 64. [Drugs used in tuberculosis and leprosy].
    Aoyagi T; Toyoda T
    Nihon Rinsho; 1990 Oct; 48(10):2212-7. PubMed ID: 2280466
    [No Abstract]   [Full Text] [Related]  

  • 65. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 66. Biochemical and hematological side effects of clofazimine in leprosy patients.
    Costa Queiroz RH; de Souza AM; Sampaio SV; Melchior E
    Pharmacol Res; 2002 Aug; 46(2):191-4. PubMed ID: 12220960
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Case of Unusual Ileal Discoloration.
    Dhillon AS; Johnston EL; Sanderson JD
    Gastroenterology; 2018 Jul; 155(1):e1-e2. PubMed ID: 28989061
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
    Cruz RCDS; Bührer-Sékula S; Penna GO; Moraes MEA; Gonçalves HS; Stefani MMA; Penna MLF; Pontes MAA; Talhari S
    An Bras Dermatol; 2018 Jun; 93(3):377-384. PubMed ID: 29924240
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Viewpoint: leprosy after the year 2000.
    Naafs B
    Trop Med Int Health; 2000 Jun; 5(6):400-3. PubMed ID: 10929138
    [No Abstract]   [Full Text] [Related]  

  • 70. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
    Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
    Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pure neural leprosy: steroids prevent neuropathy progression.
    Jardim MR; Illarramendi X; Nascimento OJ; Nery JA; Sales AM; Sampaio EP; Sarno EN
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):969-73. PubMed ID: 18094856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor necrosis factor: status in reactions in leprosy before and after treatment.
    Bhattacharya SN; Chattopadhaya D; Saha K
    Int J Dermatol; 1993 Jun; 32(6):436-9. PubMed ID: 8320025
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Coexistence of borderline tuberculoid Hansen's disease with tuberculosis verrucosa cutis in a child--a rare case.
    Ravindra K; Sugareddy ; Ramachander T
    Indian J Lepr; 2010; 82(2):91-3. PubMed ID: 21434512
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Small intestine transit anomalies in a patient with chronic abdominal pain and treated for Hansen's disease].
    Davy C; Riveau E; Bousquet JC; Curet P; Vayre P; Cortez A; Grellet J
    J Radiol; 1986 Mar; 67(3):213-8. PubMed ID: 3528476
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
    Singh H; Nel B; Dey V; Tiwari P; Dulhani N
    Lepr Rev; 2011 Mar; 82(1):17-24. PubMed ID: 21644468
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clofazimine induced pigmentation in leprosy patches.
    Chavhan SD; Jawade S
    Pan Afr Med J; 2022; 42():14. PubMed ID: 35812254
    [No Abstract]   [Full Text] [Related]  

  • 77. [Suspected leprosy].
    Velázquez de Castro y Sagarra A; López Bueno R; Gómez Jiménez G
    Aten Primaria; 1997 Jun; 20(2):107-8. PubMed ID: 9296648
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of MDT on leprosy as measured by selective indicators.
    Jesudasan K; Vijayakumaran P; Pannikar VK; Christian M
    Lepr Rev; 1988 Sep; 59(3):215-23. PubMed ID: 3264374
    [No Abstract]   [Full Text] [Related]  

  • 80. Antileprosy drugs, pregnancy and fetal outcome.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.